Seek Returns

A vs. QGEN: Agilent vs. Qiagen Stock Comparison

How do Agilent (A) and Qiagen (QGEN) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Agilent (A) and Qiagen (QGEN) are both classified in the Life Sciences Tools & Services sub-industry within the broader Life Sciences Tools & Services industry, placing them in the closest GICS peer bucket.

Company profile comparison for Agilent (A) and Qiagen (QGEN)
Profile ItemAQGEN
NameAgileThought, Inc. Class A Common StockQiagen N.V.
Country/RegionUnited StatesNetherlands
GICS SectorHealth CareHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & ServicesLife Sciences Tools & Services
GICS Sub-IndustryLife Sciences Tools & ServicesLife Sciences Tools & Services
Market Capitalization49.28 billion USD10.39 billion USD
CurrencyUSDUSD
ExchangeNYSENYSE
Listing DateNovember 18, 1999June 28, 1996
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

A
QGEN
GSPC
Loading price history…
Agilent (A) vs. Qiagen (QGEN), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Agilent (A) and Qiagen (QGEN). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Agilent (A) and Qiagen (QGEN). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Agilent (A) and Qiagen (QGEN)
MetricAQGEN
Total Return (1Y)22.92%17.09%
Total Return (3Y, Annualized)19.33%10.44%
Total Return (5Y, Annualized)3.03%-0.72%

Risk Profile

Drawdown History

A
QGEN
GSPC
Loading price history…
Agilent (A) vs. Qiagen (QGEN), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Agilent (A) and Qiagen (QGEN). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for Agilent (A) and Qiagen (QGEN)
MetricAQGEN
Volatility (1Y, Annualized)33.10%35.52%
Beta (5Y)1.220.56
Max Drawdown (5Y)-38.09%-41.97%
Avg. Volume (3M)2.25M3.68M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
A and QGEN are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Agilent (A) and Qiagen (QGEN)
MetricAQGEN
Sharpe Ratio (1Y)0.560.36
Sortino Ratio (1Y)0.960.60

Profitability

ROE (TTM)

Both Agilent (A) at 20.97% and Qiagen (QGEN) at 10.81% sit in the top peer quartile for ROE, suggesting each generates more profit from shareholders’ equity than typical industry peers.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

20.97%

Max
109.18%
A
20.97%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

10.81%

Max
109.18%
QGEN
10.81%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
Loading chart…
Agilent (A) vs. Qiagen (QGEN): A comparison of their ROE against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Net Margin (TTM)

Both Agilent (A) at 19.53% and Qiagen (QGEN) at 18.20% keep an unusually large share of revenue as bottom-line profit — each net margin clears its industry’s benchmark range.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

19.53%

A
19.53%
Max
18.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

18.20%

QGEN
18.20%
Max
18.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%
Loading chart…
Agilent (A) vs. Qiagen (QGEN): A comparison of their net margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Operating Margin (TTM)

Both Agilent (A) at 25.56% and Qiagen (QGEN) at 27.75% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

25.56%

Max
83.12%
A
25.56%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

27.75%

Max
83.12%
QGEN
27.75%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Loading chart…
Agilent (A) vs. Qiagen (QGEN): A comparison of their operating margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Profitability Metrics

Profitability metrics for Agilent (A) and Qiagen (QGEN)
MetricAQGEN
ROE (TTM)20.97%10.81%
ROA (TTM)8.63%5.68%
Net Margin (TTM)19.53%18.20%
Operating Margin (TTM)25.56%27.75%
Gross Margin (TTM)53.65%67.06%

Growth

Revenue Growth

Both Agilent (A) at 6.73% and Qiagen (QGEN) at 5.65% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Loading chart…
Agilent (A) vs. Qiagen (QGEN): A comparison of their Revenue Growth across different time periods.

EPS Growth

Qiagen (QGEN) at 409.76% clears its industry range for EPS growth, a much stronger earnings trajectory than Agilent (A) at 3.16%, which is closer to a typical peer reading.

Loading chart…
Agilent (A) vs. Qiagen (QGEN): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Agilent (A) and Qiagen (QGEN)
MetricAQGEN
Revenue Growth (YoY)6.73%5.65%
Revenue Growth (3Y CAGR)0.48%-0.81%
EPS Growth (YoY)3.16%409.76%
EPS Growth (3Y CAGR)3.02%-0.19%

Financial Strength

Current Ratio (MRQ)

Qiagen (QGEN) at 2.63 keeps current ratio within its industry’s typical mid-range, while Agilent (A) at 2.05 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for A.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.05

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
A
2.05
Min
0.10

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.63

Max
25.13
Q3
12.13
Median
5.52
QGEN
2.63
Q1
2.47
Min
0.10
Loading chart…
Agilent (A) vs. Qiagen (QGEN): A comparison of their current ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Debt / Equity (MRQ)

Both Agilent (A) at 0.56 and Qiagen (QGEN) at 0.47 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.56

Max
1.42
Q3
0.65
A
0.56
Median
0.15
Q1
0.02
Min
0.00

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.47

Max
1.42
Q3
0.65
QGEN
0.47
Median
0.15
Q1
0.02
Min
0.00
Loading chart…
Agilent (A) vs. Qiagen (QGEN): A comparison of their debt-to-equity ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Financial Strength Metrics

Financial strength metrics for Agilent (A) and Qiagen (QGEN)
MetricAQGEN
Current Ratio (MRQ)2.052.63
Debt / Equity (MRQ)0.560.47
Net Debt / EBITDA1.151.08

Dividends

Dividend Yield (TTM)

Both Agilent (A) at 0.59% and Qiagen (QGEN) at 0.71% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.59%

A
0.59%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.71%

QGEN
0.71%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Agilent (A) vs. Qiagen (QGEN): A comparison of their dividend yield against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Payout Ratio (TTM)

Both Agilent (A) at 19.98% and Qiagen (QGEN) at 18.21% pay out more of their earnings than any of their industry peers — the thinnest cover in their groups, so dividend headroom deserves attention.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

19.98%

A
19.98%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

18.21%

QGEN
18.21%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Agilent (A) vs. Qiagen (QGEN): A comparison of their payout ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Metrics

Dividend metrics for Agilent (A) and Qiagen (QGEN)
MetricAQGEN
Dividend Yield (TTM)0.59%0.71%
Dividend Payout Ratio (TTM)19.98%18.21%

Valuation

P/E Ratio (TTM)

Both Agilent (A) at 34.47 and Qiagen (QGEN) at 27.21 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

34.47

Max
85.34
Q3
43.46
A
34.47
Median
26.69
Q1
13.30
Min
0.07

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

27.21

Max
85.34
Q3
43.46
QGEN
27.21
Median
26.69
Q1
13.30
Min
0.07
Loading chart…
Agilent (A) vs. Qiagen (QGEN): A comparison of their P/E ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/S Ratio (TTM)

On P/S ratio, both Agilent (A) at 6.68 and Qiagen (QGEN) at 4.91 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.68

Max
58.18
Q3
25.77
Median
7.30
A
6.68
Q1
3.01
Min
0.01

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

4.91

Max
58.18
Q3
25.77
Median
7.30
QGEN
4.91
Q1
3.01
Min
0.01
Loading chart…
Agilent (A) vs. Qiagen (QGEN): A comparison of their P/S ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/B Ratio (MRQ)

Qiagen (QGEN) at 2.99 is valued about in line with its industry on P/B ratio, while Agilent (A) at 6.69 carries an above-peer premium to book — A is pricier on assets.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.69

Max
13.53
A
6.69
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.99

Max
13.53
Q3
6.54
Median
3.25
QGEN
2.99
Q1
1.69
Min
-5.59
Loading chart…
Agilent (A) vs. Qiagen (QGEN): A comparison of their P/B ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Valuation Metrics

Valuation metrics for Agilent (A) and Qiagen (QGEN)
MetricAQGEN
P/E Ratio (TTM)34.4727.21
P/S Ratio (TTM)6.684.91
P/B Ratio (MRQ)6.692.99
Free Cash Flow Yield (TTM)2.15%3.62%